Who is eligible To be eligible for transitional access, patients must either: be receiving private treatment with the cancer medicine at the time Pharmac begins its public funding; or start treatment ...

Starting from 1 July 2025, when a cancer medicine starts to be funded by Pharmac, patients in private facilities will be able to continue their treatment with publicly funded medicines in the same ...

The Director for Radiation Safety (the Director) intends to review the Code of Practice for Sealed Radioactive Material: ORS C12 2020 (ORS C12 2020). The review will be conducted in accordance with ...

This rest home has been audited against the Health and Disability Services Standards. During the last audit, the auditors identified some areas for improvement. Issues from their last audit are listed ...

From February 2026, General practitioners (GPs) and nurse practitioners will be able to start medical treatment for adults with ADHD, following decisions by Medsafe and Pharmac. This is a change to ...

The Director for Radiation Safety (the Director) intends to review the Code of Practice for Irradiating Apparatus: ORS C10 2020 (ORS C10 2020). The review will be conducted in accordance with section ...

Medsafe has given a New Zealand psychiatrist approval to prescribe medicinal psilocybin for treating treatment-resistant depression. This is the first time psilocybin will be prescribed outside of a ...

The Director for Radiation Safety (the Director) intends to review the Code of Practice for Veterinary Radiation: ORS C9 2020 (ORS C9 2020). The review will be conducted in accordance with section 90 ...

View all files and formats The strategic direction for preventing suicide in New Zealand is set by Every Life Matters – He Tapu te Oranga o ia Tangata: Suicide Prevention Strategy 2019-2029. The ...

The Cost Recovery Impact Statement for the Problem Gambling Levy 2025 was prepared to support development of the Strategy to Prevent and Minimise Gambling Harm 2025/26 to 2027/28. The cost of the ...